Skip to content

i-FACTOR Peptide Enhanced Bone Graft 700-025Recalls & reported problems

Cerapedics Inc. · i-FACTOR Putty, 2.5cc Syringe · Class 3 · Implant

All models of i-FACTOR Peptide Enhanced Bone Graft (4)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00850001680011), received between Sep 30, 2025 and Sep 30, 2025 — classified as 1 injury.

The most frequently reported specific device problem is “Migration” (1 report).

1 other recall cover devices cleared under the same FDA submission (P140019); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 1 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Migration1

Patient problems

  • Neuralgia1
  • Neuropathy1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjurySep 30, 2025Migration; Migration

    THE PATIENT UNDERWENT A MULTI-LEVEL CERVICAL SPINE FUSION PROCEDURE USING I-FACTOR PEPTIDE ENHANCED BONE GRAFT. POSTOPERATIVELY, THE PATIENT DEVELOPED ACUTE C5 AND C6 RADICULOPATHIES, PRESENTING WITH PAIN AND SIGNS CONSISTENT WITH NEURAL IMPINGEMENT. IMAGING PROVIDED BY THE SURGEON INDICATED POSSIBLE MIGRATION OF GRAFT MATERIAL FROM THE INTENDED SITE, WHICH MAY HAVE CONTRIBUTED TO NERVE ROOT COMPRESSION. THE OPERATIVE REPORT NOTED MECHANICAL NECK PAIN AND ACUTE RADICULOPATHY. WHILE THE EXACT ROOT CAUSE OF THE ADVERSE EVENT CANNOT BE CONCLUSIVELY ATTRIBUTED TO THE DEVICE, GRAFT MIGRATION IS A KNOWN RISK ASSOCIATED WITH BONE GRAFTING PROCEDURES AND IS LISTED IN THE DEVICE'S INSTRUCTIONS FOR USE (IFU). REVISION SURGERY WAS PERFORMED DUE TO THE SEVERITY OF SYMPTOMS, AND THE PATIENT HAS RECOVERED AND IS IMPROVING.

    Patient problems: Neuralgia; Neuropathy

    MAUDE report 23183597 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P140019. One submission often covers many models, so check the product and lot details in each record.

  • Z-1056-2022 · Apr 14, 2022 · Terminated
    putty i-FACTOR Peptide Enhanced Bone Graft 1.0cc Syringe REF 700-010, PUTTY

Other Filler, Bone Void, Synthetic Peptide devices

All Filler, Bone Void, Synthetic Peptide devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page